Is Omaxe overvalued or undervalued?

As of November 13, 2020, Omaxe is considered overvalued and in a risky financial position due to negative valuation ratios, despite a recent stock return of 45.66%, contrasting sharply with its long-term performance of -47.56% compared to the Sensex's 142.99%.

As of 13 November 2020, the valuation grade for Omaxe has moved from expensive to risky, indicating a shift in perception regarding its financial health. The company is currently considered overvalued, given its negative PE ratio of -2.68, a price-to-book value of -8.97, and an EV to EBITDA ratio of -3.11. These ratios suggest significant financial distress, particularly with negative returns on capital employed and equity.<BR><BR>In comparison to its peers, Omaxe stands out with a notably lower PEG ratio of 0.00, while competitors like DLF and Macrotech Development are categorized as very expensive, with PE ratios of 46.64 and 54.71, respectively. The stark contrast in valuations highlights Omaxe's precarious position in the market. Despite a recent one-month stock return of 45.66%, which outperformed the Sensex's 3.85%, the overall long-term performance remains concerning, particularly with a five-year return of -47.56% compared to the Sensex's 142.99%.

how big is Omaxe?

As of Jun 06, Omaxe Ltd has a market capitalization of 1,852.60 Cr, with recent net sales of 1,560.99 Cr and a net profit of -686.01 Cr. Shareholder's funds are 480.41 Cr, and total assets amount to 13,291.67 Cr.

Market Cap: As of Jun 06, Omaxe Ltd has a market capitalization of 1,852.60 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Omaxe reported a sum of Net Sales of 1,560.99 Cr and a sum of Net Profit of -686.01 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. The Shareholder's Funds amount to 480.41 Cr, while the Total Assets are valued at 13,291.67 Cr.

What does Omaxe do?

Omaxe Ltd is a small-cap realty company focused on construction and contracting, with recent quarterly net sales of ₹541 Cr and a net loss of ₹148 Cr. It was founded in 1989 and became a public company in 1999, currently holding a market cap of ₹1,853 Cr.

Overview:<BR>Omaxe Ltd is a small-cap company operating in the realty industry, primarily engaged in construction and contracting.<BR><BR>History:<BR>Omaxe Ltd was incorporated as Omaxe Construction Private Limited on 8th March 1989. It transitioned to a Public Limited Company in 1999 and changed its name to Omaxe Limited on June 6, 2006. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 541 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -148 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 1,853 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 45<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.25<BR>- Return on Equity: 334.43%<BR>- Price to Book: -9.36<BR><BR>Contact Details:<BR>- Address: Shop 19-B First Floor Sohna Rd, Omaxe Celebration Mall Gurgaon Haryana : 122001<BR>- Tel: 91-11-41896680-85/41896676/4189679<BR>- Email: sales@omaxe.com/vrr@omaxe.com<BR>- Website: http://www.omaxe.com

What is the bonus history of the Omaxe?

Omaxe Ltd's bonus history includes a significant issue at a ratio of 10:39, announced on November 11, 2013, where shareholders received 10 additional shares for every 39 shares held.

Omaxe Ltd has a bonus history that includes a significant bonus issue announced at a ratio of 10:39. This bonus was issued with an ex-date of November 11, 2013, and the record date was November 12, 2013. This means that for every 39 shares held, shareholders received an additional 10 shares. If you have any more questions about Omaxe or need further details, feel free to ask!

Has Omaxe declared dividend?

Omaxe Ltd has declared a 7% dividend, amounting to ₹0.7 per share, but the dividend yield is currently 0%. Total returns over various periods show mixed performance, with significant gains over 1 and 2 years, while the 5-year period reflects a substantial loss of -46.33%.

Omaxe Ltd has declared a 7% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 7%<BR>- Amount per share: 0.7<BR>- Ex-date: 19 Sep 19<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>Over the 6-month period, the price return was -9.24%, with a dividend return of 0%, resulting in a total return of -9.24%.<BR><BR>In the 1-year period, the price return was 16.57%, with a dividend return of 0%, leading to a total return of 16.57%.<BR><BR>For the 2-year period, the price return was 95.78%, while the dividend return remained at 0%, resulting in a total return of 95.78%.<BR><BR>During the 3-year period, the price return was 14.08%, with no dividend return, culminating in a total return of 14.08%.<BR><BR>In the 4-year period, the price return was 24.82%, and the dividend return was 0%, resulting in a total return of 24.82%.<BR><BR>Over the 5-year period, the price return was -46.33%, with a dividend return of 0%, leading to a total return of -46.33%.<BR><BR>Overall, Omaxe Ltd has declared a dividend, but the dividend yield is currently 0%. The total returns over various periods show a mix of positive and negative performance, with significant gains over 1 and 2 years, while the 5-year period reflects a substantial loss.

Who are the peers of the Omaxe?

Omaxe's peers include DLF, Macrotech Developers, Godrej Properties, Prestige Estates, Oberoi Realty, and others. Omaxe has below-average management risk and growth, with a 1-year return of 10.60%, higher than Kesar India but lower than Arih.Found.Hsg.

Peers: The peers of Omaxe are DLF, Macrotech Devel., Godrej Propert., Prestige Estates, Oberoi Realty, Suraj Estate, Elpro Internatio, Arihant Super., and Kesar India.<BR><BR>Quality Snapshot: Excellent management risk is observed at Macrotech Devel. and Oberoi Realty, while Good management risk is found at Suraj Estate. Average management risk is present at DLF, Godrej Propert., Prestige Estates, Elpro Internatio, and Arihant Super., and the rest. Below Average management risk is noted at Omaxe and Arih.Found.Hsg. In terms of growth, Excellent growth is seen at Macrotech Devel. and Kesar India, while Average growth is found at DLF, Suraj Estate, and Elpro Internatio. Below Average growth is present at Godrej Propert., Prestige Estates, Omaxe, Arihant Super., and the rest. Good capital structure is noted at DLF and Kesar India, while Excellent capital structure is found at Oberoi Realty. Below Average capital structure is observed at Macrotech Devel., Godrej Propert., Prestige Estates, Omaxe, Suraj Estate, Elpro Internatio, Arihant Super., and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Arih.Found.Hsg. at 808.25%, while Kesar India has the lowest at -15.51%. Omaxe's 1-year return of 10.60% is higher than Kesar India's but lower than Arih.Found.Hsg. Negative six-month returns are noted for Suraj Estate, Elpro Internatio, Kesar India, and the rest.

Who are in the management team of Omaxe?

As of March 2022, the management team of Omaxe includes Rohtas Goel (Chairman & Wholetime Director), Mohit Goel (Managing Director), Vinit Goyal (Whole-time Director), and several independent directors: Gurnam Singh, Shridhar Rao, and Nishal Jain, along with Vikas Khandelwal as Company Secretary & Compliance Officer.

As of March 2022, the management team of Omaxe includes the following individuals:<BR><BR>1. Rohtas Goel - Chairman & Wholetime Director<BR>2. Gurnam Singh - Independent Director<BR>3. Shridhar Rao - Independent Director<BR>4. Nishal Jain - Independent Director<BR>5. Mohit Goel - Managing Director<BR>6. Vinit Goyal - Whole-time Director<BR>7. Vikas Khandelwal - Company Secretary & Compliance Officer<BR><BR>The team comprises a mix of executive and independent directors, each contributing to the governance and strategic direction of the company.

Who are the top shareholders of the Omaxe?

The top shareholders of Omaxe include Guild Builders Pvt Ltd with 63.57%, foreign institutional investors holding 7.38%, and Unico Global Opportunities Fund Limited as the largest public shareholder with 3.48%. Individual investors own 11.17%, and there are no mutual funds currently invested in Omaxe.

The top shareholders of Omaxe include the promoters, who hold the majority of the shares. The promoter with the highest holding is Guild Builders Pvt Ltd, which owns 63.57% of the company. Additionally, foreign institutional investors (FIIs) hold 7.38% of the shares, represented by 10 different FIIs. The highest public shareholder is Unico Global Opportunities Fund Limited, with a stake of 3.48%. Individual investors collectively hold 11.17% of the shares. It's worth noting that there are currently no mutual funds holding shares in Omaxe.

When is the next results date for Omaxe?

The next results date for Omaxe is 13 August 2025.

The next results date for Omaxe is scheduled for 13 August 2025.

Are Omaxe latest results good or bad?

Omaxe's latest financial results are negative, with a significant decline in net sales by 27.7% and a profit before tax of Rs -243.88 crore. Despite an increase in cash reserves and an improved debt-equity ratio, the overall performance reflects substantial challenges.

Omaxe's latest financial results for the quarter ending June 2025 indicate a challenging period for the company. The financial score has significantly dropped to -18, reflecting a negative performance trend compared to the previous quarter's score of -1.<BR><BR>Key highlights include a substantial decline in net sales, which fell to Rs 282.24 crore, marking a decrease of 27.7% compared to the average of the previous four quarters and the lowest sales recorded in the last five quarters. Additionally, the company reported a profit before tax of Rs -243.88 crore, which is a 16.1% decrease from the previous average.<BR><BR>On a slightly positive note, Omaxe has seen an increase in cash and cash equivalents, reaching Rs 743.92 crore, the highest in the last six half-yearly periods. The debt-equity ratio has also improved to -3.88 times, indicating a reduction in borrowing relative to equity capital.<BR><BR>However, the overall financial performance reflects significant challenges, with net profit showing a decline of 25.24% and interest expenses rising to Rs 67.03 crore, the highest in five quarters. Given these results, it can be concluded that Omaxe's latest performance is more negative than positive.

Is Omaxe technically bullish or bearish?

As of 27 October 2025, Omaxe's technical trend has shifted to bearish, with strong indications of weakness supported by bearish MACD, moving averages, and KST, despite some divergence shown by a bullish OBV on the monthly timeframe.

As of 27 October 2025, the technical trend for Omaxe has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly and monthly MACD are both bearish, reinforcing the negative outlook. The daily moving averages also confirm a bearish trend. Additionally, the KST is bearish on both weekly and monthly time frames. While the Bollinger Bands indicate a mildly bearish stance, the OBV shows a bullish trend on the monthly, suggesting some divergence. Overall, the bearish indicators dominate, reflecting a weak technical position for Omaxe.

How has been the historical performance of Omaxe?

Omaxe's historical performance shows fluctuating net sales, peaking at 1,614.32 Cr in March 2024 but declining to 1,560.99 Cr in March 2025, alongside significant losses, with profit after tax dropping to -685.13 Cr. The company faces increasing liabilities and a challenging financial environment, despite a slight improvement in cash flow from operations.

Answer:<BR>The historical performance of Omaxe shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.<BR><BR>Breakdown:<BR>Omaxe's net sales peaked at 1,614.32 Cr in March 2024 but declined to 1,560.99 Cr in March 2025. The total operating income followed a similar pattern, reaching 1,614.32 Cr in March 2024 and then decreasing to 1,560.99 Cr in March 2025. The company faced substantial challenges, reflected in its operating profit (PBDIT), which fell to -531.76 Cr in March 2025 from -322.70 Cr in March 2024. Profit before tax also worsened, dropping to -763.75 Cr in March 2025 from -507.30 Cr in the previous year. Consequently, profit after tax showed a similar decline, resulting in a loss of -685.13 Cr in March 2025 compared to -406.14 Cr in March 2024. The company's total liabilities increased to 14,265.08 Cr in March 2025, up from 13,291.67 Cr in March 2024, while total assets also rose to 14,265.08 Cr. Cash flow from operating activities improved slightly to 1,006.00 Cr in March 2025, compared to 986.00 Cr in March 2024, but cash flow from financing activities remained negative at -770.00 Cr. Overall, Omaxe's financial performance indicates a challenging environment with increasing losses and a rising debt burden.

Should I buy, sell or hold Omaxe?

Why is Omaxe falling/rising?

As of 04-Dec, Omaxe Ltd's stock price is declining, currently at Rs 68.46, with a significant year-to-date drop of 38.27%. The company's poor financial health, negative book value, and reduced institutional investor participation indicate a lack of confidence in its future prospects.

As of 04-Dec, Omaxe Ltd's stock price is falling, currently at Rs 68.46, reflecting a decrease of Rs 1.48 or 2.12%. This decline is part of a broader trend, as the stock has underperformed significantly compared to the benchmark Sensex, with a 1-week drop of 1.76% against the Sensex's 0.53% decline, and a staggering 38.27% drop year-to-date compared to the Sensex's 9.12% gain.<BR><BR>The company's financial health is concerning, highlighted by a negative book value and a weak long-term fundamental strength. Over the last five years, Omaxe's operating profit has decreased at an alarming annual rate of 240.34%. Additionally, the company has a high debt-to-EBITDA ratio of -1.00 times, indicating low ability to service its debt. Recent financial results have also been disappointing, with net sales falling by 14.5% in the last quarter compared to the previous four-quarter average, and a significant loss before tax of Rs 242.00 crore.<BR><BR>Investor sentiment appears to be negatively impacted, as evidenced by a decrease in institutional investor participation, which has dropped by 1.3% in the previous quarter. Institutional investors typically have more resources to analyze company fundamentals, and their reduced stake may signal a lack of confidence in Omaxe's future prospects. Furthermore, the stock is trading below all key moving averages, indicating a bearish trend.<BR><BR>Overall, the combination of poor financial performance, declining investor confidence, and underperformance relative to benchmarks contributes to the ongoing decline in Omaxe's stock price.

Which are the latest news on Omaxe?